
Stanley Gilreath
Examiner (ID: 8503)
| Most Active Art Unit | 2405 |
| Art Unit(s) | 2405, 2402, 2605, 2899 |
| Total Applications | 1421 |
| Issued Applications | 1259 |
| Pending Applications | 3 |
| Abandoned Applications | 159 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6134968
[patent_doc_number] => 20110008792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'PROMOTERS FOR EXPRESSION IN MODIFIED VACCINIA VIRUS ANKARA'
[patent_app_type] => utility
[patent_app_number] => 12/879119
[patent_app_country] => US
[patent_app_date] => 2010-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8254
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008792.pdf
[firstpage_image] =>[orig_patent_app_number] => 12879119
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/879119 | PROMOTERS FOR EXPRESSION IN MODIFIED VACCINIA VIRUS ANKARA | Sep 9, 2010 | Abandoned |
Array
(
[id] => 5992589
[patent_doc_number] => 20110014242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'PROMOTERS FOR EXPRESSION IN MODIFIED VACCINIA VIRUS ANKARA'
[patent_app_type] => utility
[patent_app_number] => 12/879101
[patent_app_country] => US
[patent_app_date] => 2010-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8255
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014242.pdf
[firstpage_image] =>[orig_patent_app_number] => 12879101
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/879101 | PROMOTERS FOR EXPRESSION IN MODIFIED VACCINIA VIRUS ANKARA | Sep 9, 2010 | Abandoned |
| 61/460767 | REGULATORY ELEMENT FOR HETEROLOGOUS PROTEIN PRODUCTION IN THE FRUITING BODY OF FILAMENTOUS FUNGI | Aug 29, 2010 | Pending |
Array
(
[id] => 9608009
[patent_doc_number] => 08785174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Heavy metal remediation system'
[patent_app_type] => utility
[patent_app_number] => 12/859590
[patent_app_country] => US
[patent_app_date] => 2010-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 13371
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12859590
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/859590 | Heavy metal remediation system | Aug 18, 2010 | Issued |
Array
(
[id] => 8323915
[patent_doc_number] => 20120196323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'Fermentation Process'
[patent_app_type] => utility
[patent_app_number] => 13/389913
[patent_app_country] => US
[patent_app_date] => 2010-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15917
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/389913 | Fermentation Process | Aug 1, 2010 | Abandoned |
Array
(
[id] => 8005703
[patent_doc_number] => 08084252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Recombinant cell clones having increased stability and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 12/848897
[patent_app_country] => US
[patent_app_date] => 2010-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6929
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084252.pdf
[firstpage_image] =>[orig_patent_app_number] => 12848897
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/848897 | Recombinant cell clones having increased stability and methods of making and using the same | Aug 1, 2010 | Issued |
Array
(
[id] => 8253335
[patent_doc_number] => 20120157659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'AFFINITY PEPTIDES AND METHOD FOR PURIFICATION OF RECOMBINANT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/842764
[patent_app_country] => US
[patent_app_date] => 2010-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14153
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157659.pdf
[firstpage_image] =>[orig_patent_app_number] => 12842764
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/842764 | AFFINITY PEPTIDES AND METHOD FOR PURIFICATION OF RECOMBINANT PROTEINS | Jul 22, 2010 | Abandoned |
Array
(
[id] => 6608588
[patent_doc_number] => 20100323400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Compositions and Methods for Controlling Copy Number for a Broad Range of Plasmids and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/837466
[patent_app_country] => US
[patent_app_date] => 2010-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8609
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0323/20100323400.pdf
[firstpage_image] =>[orig_patent_app_number] => 12837466
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/837466 | Compositions and Methods for Controlling Copy Number for a Broad Range of Plasmids and Uses Thereof | Jul 14, 2010 | Abandoned |
Array
(
[id] => 6342717
[patent_doc_number] => 20100329990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'LUMINESCENT MARKERS'
[patent_app_type] => utility
[patent_app_number] => 12/819928
[patent_app_country] => US
[patent_app_date] => 2010-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18811
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0329/20100329990.pdf
[firstpage_image] =>[orig_patent_app_number] => 12819928
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/819928 | LUMINESCENT MARKERS | Jun 20, 2010 | Abandoned |
Array
(
[id] => 6235340
[patent_doc_number] => 20100267044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'GENETICALLY ENGINEERED BIOLOGICAL INDICATOR'
[patent_app_type] => utility
[patent_app_number] => 12/816463
[patent_app_country] => US
[patent_app_date] => 2010-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11956
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267044.pdf
[firstpage_image] =>[orig_patent_app_number] => 12816463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/816463 | Genetically engineered biological indicator | Jun 15, 2010 | Issued |
Array
(
[id] => 6382839
[patent_doc_number] => 20100317009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'Method for DNA Double-Strand Break Repair in Vitro and Applications Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/796258
[patent_app_country] => US
[patent_app_date] => 2010-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12173
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317009.pdf
[firstpage_image] =>[orig_patent_app_number] => 12796258
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/796258 | Method for DNA double-strand break repair in vitro and applications thereof | Jun 7, 2010 | Issued |
Array
(
[id] => 6396974
[patent_doc_number] => 20100304490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'METHOD FOR GENERATING A GENETICALLY MODIFIED MICROBE'
[patent_app_type] => utility
[patent_app_number] => 12/791717
[patent_app_country] => US
[patent_app_date] => 2010-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15115
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20100304490.pdf
[firstpage_image] =>[orig_patent_app_number] => 12791717
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/791717 | Method for generating a genetically modified microbe | May 31, 2010 | Issued |
Array
(
[id] => 6622493
[patent_doc_number] => 20100311065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'GENETICALLY MODIFIED MICROBES PRODUCING ISOPRENOIDS'
[patent_app_type] => utility
[patent_app_number] => 12/791596
[patent_app_country] => US
[patent_app_date] => 2010-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23971
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311065.pdf
[firstpage_image] =>[orig_patent_app_number] => 12791596
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/791596 | GENETICALLY MODIFIED MICROBES PRODUCING ISOPRENOIDS | May 31, 2010 | Abandoned |
Array
(
[id] => 8005701
[patent_doc_number] => 08084251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Recombinant cell clones having increased stability and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 12/778776
[patent_app_country] => US
[patent_app_date] => 2010-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 6926
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084251.pdf
[firstpage_image] =>[orig_patent_app_number] => 12778776
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/778776 | Recombinant cell clones having increased stability and methods of making and using the same | May 11, 2010 | Issued |
Array
(
[id] => 8173431
[patent_doc_number] => 20120108445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'VEGF AND VEGFR1 GENE EXPRESSION USEFUL FOR CANCER PROGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/265538
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14112
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108445.pdf
[firstpage_image] =>[orig_patent_app_number] => 13265538
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265538 | VEGF AND VEGFR1 GENE EXPRESSION USEFUL FOR CANCER PROGNOSIS | Apr 22, 2010 | Abandoned |
Array
(
[id] => 6499286
[patent_doc_number] => 20100209931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Compositions for Identifying Novel Compositions for the Treatment of Disease and Methods of Using Same'
[patent_app_type] => utility
[patent_app_number] => 12/705781
[patent_app_country] => US
[patent_app_date] => 2010-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18986
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209931.pdf
[firstpage_image] =>[orig_patent_app_number] => 12705781
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/705781 | Compositions for Identifying Novel Compositions for the Treatment of Disease and Methods of Using Same | Feb 14, 2010 | Abandoned |
Array
(
[id] => 8164145
[patent_doc_number] => 08173429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Characterization of the I-Spomi endonuclease from fission yeast'
[patent_app_type] => utility
[patent_app_number] => 12/689513
[patent_app_country] => US
[patent_app_date] => 2010-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 20120
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173429.pdf
[firstpage_image] =>[orig_patent_app_number] => 12689513
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/689513 | Characterization of the I-Spomi endonuclease from fission yeast | Jan 18, 2010 | Issued |
Array
(
[id] => 7744167
[patent_doc_number] => 20120021941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'BLOOD TEST FOR THE DETECTION OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/144250
[patent_app_country] => US
[patent_app_date] => 2010-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11999
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021941.pdf
[firstpage_image] =>[orig_patent_app_number] => 13144250
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/144250 | BLOOD TEST FOR THE DETECTION OF CANCER | Jan 11, 2010 | Abandoned |
Array
(
[id] => 6096419
[patent_doc_number] => 20110003385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS'
[patent_app_type] => utility
[patent_app_number] => 12/684784
[patent_app_country] => US
[patent_app_date] => 2010-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 32380
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003385.pdf
[firstpage_image] =>[orig_patent_app_number] => 12684784
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/684784 | REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS | Jan 7, 2010 | Abandoned |
Array
(
[id] => 8006391
[patent_doc_number] => 08084596
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Regulated apoptosis'
[patent_app_type] => utility
[patent_app_number] => 12/684064
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 35
[patent_no_of_words] => 36173
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12684064
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/684064 | Regulated apoptosis | Jan 6, 2010 | Issued |